Explicyte and Institut Bergonié partners for comprehensive translational research programs in immuno-oncology
03 / 25 / 2019
Bordeaux, FRANCE, March 24, 2019: Explicyte and Institut Bergonié, have entered into a collaboration to conjointly drive a translational research program aiming at identifying resistance mechanisms to immune checkpoint inhibitors in cancer patients.